Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ju-Yeon Cho | - |
dc.contributor.author | Young-Sun Lee | - |
dc.contributor.author | Soon Sun Kim | - |
dc.contributor.author | Do Seon Song | - |
dc.contributor.author | Jeong-Hoon Lee | - |
dc.contributor.author | Ji Hoon Kim | - |
dc.date.accessioned | 2021-10-26T07:40:08Z | - |
dc.date.available | 2021-10-26T07:40:08Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/54610 | - |
dc.description.abstract | [No Abstract Available.] | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한간학회 | - |
dc.title | Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3350/cmh.2021.0293 | - |
dc.identifier.scopusid | 2-s2.0-85119995260 | - |
dc.identifier.wosid | 000706507200001 | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.27, no.4, pp 515 - 523 | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 27 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 515 | - |
dc.citation.endPage | 523 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002760995 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | SARS-COV-2 INFECTION | - |
dc.subject.keywordPlus | CIRRHOTIC-PATIENTS | - |
dc.subject.keywordPlus | INJURY | - |
dc.subject.keywordPlus | VACCINATION | - |
dc.subject.keywordPlus | REMDESIVIR | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Liver cirrhosis | - |
dc.subject.keywordAuthor | Hepatitis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.